SCHEMBL3470044

SCHEMBL3470044

CCCCCC(C)CCCC(C)CCCC(C)C=CC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.51
ACHE P22303 1/20 0.44
BACE1 P56817 1/20 0.44
GPR84 Q9NQS5 4/20 0.39
CA1 P00915 2/20 0.39
FFAR1 O14842 1/20 0.39
HCAR2 Q8TDS4 2/20 0.39
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRB2 P47870 2/20 0.38
GABRA4 P48169 2/20 0.38
GABRE P78334 2/20 0.38
GABRA6 Q16445 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30527786 0.93 ACHE (0.49) ACE2ACHEBACE1GPR84CA1
SCHEMBL29177079 0.91 ACHE (0.47) ACE2ACHEBACE1GPR84CA1
SCHEMBL8965243 0.87 ACHE (0.55) ACE2ACHEBACE1GPR84CA1
SCHEMBL8965248 0.87 ACHE (0.55) ACE2ACHEBACE1GPR84CA1
SCHEMBL31511871 0.84 ACE2 (0.41) ACE2ACHEBACE1GPR84FFAR1
SCHEMBL31511868 0.79 ACHE (0.60) ACE2ACHEBACE1GPR84FFAR1
SCHEMBL900317 0.79 GABRP (0.48) ACHEBACE1HCAR2GABRPGABRD
SCHEMBL17021602 0.79 GABRP (0.48) ACHEBACE1HCAR2GABRPGABRD
SCHEMBL900319 0.79 GABRP (0.48) ACHEBACE1HCAR2GABRPGABRD
SCHEMBL8948047 0.78 CA1 (0.44) ACE2GPR84CA1FFAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140073703-A1 PHYTOL AS A CHOLESTEROL LOWERING AGENT OLOFSSON PETER (SE) 2014-03-13 US disclosed
EP-2249819-A1 PHYTOL AS A CHOLESTEROL LOWERING AGENT Olofsson, Peter (SE) 2010-11-17 EP disclosed
WO-2009113952-A1 PHYTOL AS A CHOLESTEROL LOWERING AGENT OLOFSSON PETER (SE) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140073703-A1 PHYTOL AS A CHOLESTEROL LOWERING AGENT SREBF2, PNLIP, APOL1 ACE2 758/4885ACHE 692/4885BACE1 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.